List of Publications
Hartmut Derendorf,PhD
Distinguished Professor

Email: hartmut@cop.ufl.edu
Phone: (352) 273-7856
Fax: (352) 273-7854
Email your request for a reprint to: hartmut@cop.ufl.edu

 

Last modified January 6, 2009
Most Recent Publication

  1. P. Rohdewald, H. Derendorf, C.E. Elger, O. Knoll
    Quantification of the attenuation of pain sensation through evoked potentials after the application of mild analgesics.
    Z. EEG-EMG 11, 199-204 (1980).
  2.  H. Derendorf
    Electroencephalography in drug research.
    Dtsch. Apoth. Ztg. 120, 1474-1476 (1980).
  3. H. Derendorf, P. Rohdewald
    Pharmaceutical availability of analgesic derivatives of salicylic acid.
    Dtsch. Apoth. Ztg. 121, 493-498 (1981).
  4. H. Derendorf, P. Rohdewald
    Pharmaceutical availability of analgesic derivatives of pyrazolone.
    Dtsch. Apoth. Ztg. 121, 549-552 (1981).
  5. H. Derendorf, P. Rohdewald
    Measurement of analgesic action by subjective and objective parameters.
    In "Pain research - Pain measurement - Chest pain", ed. by A. Struppler and M. Gessler, pg. 143-150, Springer (1981).
  6. H. Derendorf, P. Rohdewald
    Pharmaceutical availability of analgesic derivatives of p-aminophenol in tablets.
    Dtsch. Apoth. Ztg. 121, 653-656 (1981).
  7.  P. Rohdewald, H. Derendorf, C.E. Elger, O. Knoll
    Evoked potentials as objective parameters for the analgesic response of weak analgesics.
    Adv. in Neurology 32, 375-381 (1982).
  8.  P. Rohdewald, H. Derendorf, G. Drehsen, C.E. Elger, O. Knoll
    Changes in cortical evoked potentials as correlates of the efficacy of weak analgesics.
    Pain 12, 329-34l (1982).
  9.  H. Derendorf, G. Drehsen, P. Rohdewald
    Cortical evoked potentials and saliva levels as basis for the comparison of pure analgesic to analgesic combinations.
    Pharmacology 25, 227-236 (1982).
  10.  H. Derendorf
    Phencyclidine - angel dust or devil's drug?
    Dtsch. Apoth. Ztg. 122, 2642-2646 (1982).
  11. H. Derendorf, E.R. Garrett
    HPLC-Assay of methadone, phencyclidine and metabolites by post-column ion-pair extraction and "on-line" fluorescence detection of the counter-ion with applications.
    J. Pharm. Sci. 72, 630-635 (1983).
  12. P. Rohdewald, G. Drehsen, E. Milsmann, H. Derendorf
    Relationship between saliva levels of metamizol metabolites, bioavailability and analgesic efficacy.
    Arzneimittelforschung (Drug Research) 33(II), 985-988 (1983).
  13. H. Derendorf, G. Drehsen, P. Rohdewald
    In vivo- in vitro- correlations of salicylate saliva levels and continuous flow cell dissolution rates.
    Int. J. Pharm. 15, 167-175 (1983).
  14. H. Derendorf, A.A. El-Koussi, E.R. Garrett
    Electrochemical chromatographic determination of morphine - antagonists in biological fluids with applications.
    J. Pharm. Sci. 73, 621-624 (1984).
  15. H. Derendorf, G. Drehsen, P. Rohdewald
    Antipyrine - new light on an old drug.
    Pharm. Res. 1, 225-229 (1984).
  16. P. Rohdewald, G. Drehsen, H. Derendorf
    Phenazone, the underestimated analgesic.
    Pharm. Ztg. 129, 552-558 (1984).
  17. G. Drehsen, H. Derendorf, P. Rohdewald
    Pain relief- but when ?
    Munich. Med. Wschr. 126, 736-738 (1984).
  18. P. Rohdewald, J. Rehder, G. Drehsen, G. Hochhaus, H. Derendorf, H. Möllmann
    Simultaneous determination of glucocorticoid alcohols, their succinates and hydrocortisone in plasma.
    J. Pharm. Biomed. Anal. 3, 565-573 (1985).
  19. H. Derendorf, H. Möllmann, P. Rohdewald, J. Rehder, E.W. Schmidt
    Kinetics of methylprednisolone and its hemisuccinate ester.
    Clin. Pharm. Ther. 37, 502-507 (1985).
  20. R.L. Yost, H. Derendorf
    Rapid chromatographic determination of cefotaxime and its metabolite in biological fluids.
    J. Chromatogr. 341, 131-138 (1985).
  21. H. Derendorf, P. Rohdewald, H. Möllmann, J. Rehder, J. Barth, D. Neveling
    Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate.
    Biopharm. Drug Disp. 6, 423-432 (1985).
  22. E.R. Garrett, H. Derendorf, A. Mattha
    Pharmacokinetics of morphine and its surrogates VI: HPLC-Analyses and pharmacokinetics of methadone and its derived metabolites in dogs.
    J. Pharm. Sci. 74, 1203-1214 (1985).
  23. H. Möllmann, P. Rohdewald, E.W. Schmidt, V. Salomon, H. Derendorf
    Pharmacokinetics of triamcinolone acetonide and its phosphate ester.
    Eur. J. Clin. Pharmacol. 29, 85-89 (1985).
  24. P. Rohdewald, H. Derendorf, G. Drehsen, H.W. Granitzki, E. Neddermann
    The attenuation of experimental pain by pyrazolones.
    In "100 years pyrazolones", ed. by K. Brune and R. Lanz, Urban & Schwarzenberg, pg. 61-67 (1985).
  25. H. Möllmann, J. Barth, K.M. Müller, P. Rohdewald, A. Grüner, H. Derendorf
    Pulmonary complications in intensive care patients- therapeutic approaches for the treatment of ARDS
    BGA-Schriften 486, 193-207 (1986).
  26. H. Derendorf, P. Rohdewald, G. Hochhaus, H. Möllmann
    HPLC determination of glucocorticoid alcohols, their phosphates and hydrocortisone in aqueous solutions and biological fluids.
    J. Pharm. Biomed. Anal. 4, 197-206 (1986).
  27. H. Derendorf, G. Mullersman, J. Barth, A. Grüner, H. Möllmann
    Pharmacokinetics of diclofenac sodium after intramuscular administration in combination with triamcinolone acetate.
    Eur. J. Clin. Pharmacol. 31, 363-365 (1986).
  28. G. Mullersman, H. Derendorf
    Ranitidine - rapid analysis in biological fluids and determination of erythrocyte partitioning.
    J. Chromatogr. 381, 385-391 (1986).
  29. G. Mullersman, V.P. Gotz, W.L. Russell, H. Derendorf
    Lack of clinically significant in vitro and in vivo interactions between ranitidine and sucralfate.
    J. Pharm. Sci. 75, 995-998 (1986).
  30. R.L. Yost, H. Derendorf
    Pharmacokinetics of cefotaxime and its metabolite in normal and morbidly obese patients.
    Ther. Drug Monitor. 8, 189-194 (1986).
  31. H. Derendorf, H. Möllmann, A. Grüner, D. Haack, G. Gyselby
    Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intraarticular administration.
    Clin. Pharm. Ther. 39, 313-317 (1986).
  32. H. Möllmann, J. Rehder, P. Rohdewald, B.E. Braun, J. Barth, H. Derendorf, B. Holtmann, A. Grüner
    Exogenous and endogenous glucocorticoid plasma level after intramuscular administration of diclofenac and triamcinolone diacetate
    Med. Welt 37, 371-377 (1986).
  33. H. Möllmann, J. Barth, D. Haack, A. Grüner, D. Stroband G. Gyselby, P. Rohdewald, H. Derendorf
    Comparison of the kinetics and dynamics of intraarticular glucocorticoid suspensions.
    Akt. Rheumatol. 11, 55-60 (1986).
  34. H. Derendorf, M. Kaltenbach
    Coulometric high-performance liquid chromatographic-analysis morphine in biological fluids.
    J. Pharm. Sci. 75, 1198-1200 (1986).
  35. P. Rohdewald, H. Möllmann, J. Barth, J. Rehder, H. Derendorf
    Pharmacokinetics of dexamethasone and its phosphate ester.
    Biopharm. Drug Disp. 8, 205-212 (1987).
  36. S.A. Stout, H. Derendorf
    Local treatment of respiratory infections with antibiotics.
    Drug Intel. Clin. Pharm. 21, 322-329 (1987).
  37. H. Derendorf
    Erythrocyte - binding of cepholosporins.
    J. Pharm. Pharmacol. 39, 129-131 (1987).
  38. P. Rohdewald, J. Rehder, H. Möllmann, J. Barth, H. Derendorf
    Pharmacokinetics and pharmacodynamics of prednisolone after extremely high doses of prednisolone hemisuccinate.
    Arzneimittelforschung (Drug Research), 37 (I), 194-198 (1987).
  39. G. Mullersman, S. Toufflin, H. Derendorf
    HPLC analysis of buprenorphine in plasma and urine using coulometric detection.
    J. Pharm. Biomed. Anal. 5, 303-308 (1987).
  40. S.A. Stout, C.M. Riley, H. Derendorf
    The correlation between the pharmacokinetics of melphalan and the pharmacodynamic response of neuroblastoma cells treated in vitro.
    Proc. Biopharm. Pharmacokin. II, 252-260 (1987).
  41. H. Derendorf
    Pharmacokinetic evaluation of cefotaxime in normal and obese subjects.
    Proc. Biopharm. Pharmacokin. III, 11-18 (1987).
  42. H. Möllmann, P. Rohdewald, J. Barth, H. Derendorf
    Effect of high doses of glucocorticoids on the kinetics of human white blood cells in vivo.
    Med. Klinik 83, 159-163 (1988).
  43. G. Mullersman, H. Derendorf, M.E. Brewster, K.S. Estes, N. Bodor
    HPLC-Assay of a CNS directed estradiol chemical delivery system and its application after intravenous administration to rats.
    Pharm. Res. 5, 172-177 (1988).
  44. H. Möllmann, P. Rohdewald, J. Barth, H. Derendorf, C. Möllmann, M. Verho.
    Comparative pharmacokinetics of methylprednisolone phosphate and hemisuccinate in high doses.
    Pharm. Res. 5, 509-513 (1988).
  45. L.A. Berglund, H. Derendorf, J.W. Simpkins
    Desensitization of brain opiate receptor mechanisms by gonadal steroid treatments that stimulate luteinizing hormone secretion.
    Endocrinology 122, 2718-2726 (1988).
  46. R.W. Townsend, V. Keuth, K. Embil, G. Mullersman, J.H. Perrin, H. Derendorf
    High-performance liquid chromatographic determination of conjugated estrogens in tablets.
    J. Chromatogr. 450, 414-419 (1988).
  47. J. Limberg, H. Derendorf
    Pharmacy education in the U.S.A.
    Deut. Apoth. Ztg. 128, 2458-2461 (1988).
  48. E.W. Schmidt, H.W. Möllmann, B.E. Braun, J. Barth, H. Derendorf
    Circadian theophylline levels after single and multiple administration of a sustained released dosage form.
    Therapiewoche 38, 2046-2051 (1988).
  49. M.E. Brewster, K.S. Estes, T. Loftsson, R. Perchalski H. Derendorf, G. Mullersman, N. Bodor
    Improved delivery through biological membranes XXXI: Solubilization and stabilization of an estradiol chemical delivery system by modified ß-cyclodextrins.
    J. Pharm. Sci. 77, 981-985 (1988).
  50. H. Derendorf
    Pharmacokinetic evaluation of b-lactam antibiotics.
    J. Antimicrob. Chemother. 24, 407-413 (1989).
  51. H. Möllmann, J. Barth, D. Schött, W.T. Ulmer, H. Derendorf, G. Hochhaus
    Differential therapeutic aspects of the treatment of toxic gas poisoning with glucocorticoids.
    Intensivmed. 26, 2-15 (1989).
  52. M.E. Brewster, T. Loftsson, K.E. Estes, G. Mullersman, H. Derendorf, N. Bodor
    Water soluble complexes of a brain-targeted drug delivery system.
    Proc. Intl. Symp. Cyclodextr. 4, 399-405 (1989).
  53. H. Möllmann, P. Rohdewald, J. Barth, M. Verho, H. Derendorf
    Pharmacokinetics and dose linearity testing of methylprednisolone phosphate.
    Biopharm. Drug Disp. 10, 453-464 (1989).
  54. H. Derendorf, H. Möllmann, P. Rohdewald, D. Strohband, J. Barth, G. Hochhaus
    Pharmacokinetic aspects of intra-articular administration of glucocorticoids.
    in Willert, Heuck (ed.), New Results in Osteology, Springer, Berlin, pp. 474-481 (1989).
  55. J. Barth, H.W. Möllmann, H. Derendorf, G. Hochhaus
    Pharmacodynamic interactions in systemic glucocorticoid therapy.
    in Willert, Heuck (ed.), New Results in Osteology, Springer, Berlin, pp. 533-541 (1989).
  56. J. Barth, A. Möllmann, G. Hochhaus, H. Derendorf, H.W. Möllmann
    Absorption and transfer of water-soluble glucocorticoids through pulmonary membranes.
    Atemw.-Lungenkrkh. 15, 412-416 (1989).
  57. E.W. Schmidt, H. Derendorf, B. Rasche, H.W. Möllmann
    Clinical and pharmacokinetic evaluation for the replacement therapy of a1-protease-inhibitor in patients with congenital a1-protease-inhibitor deficiency and lung emphysema.
    Atemw.-Lungenkrkh. 15, 479-488 (1989).
  58. H.G. Schaefer, D. Harrison, M.P. Hocking, J. Limberg, H. Derendorf
    Effect of truncal vagotomy and partial gastrectomy on the pharmacokinetics of propranolol enantiomers in dogs.
    J. Pharm. Sci. 79, 292-294 (1990).
  59. H. Schreier, G. Hochhaus, R.J. Prankerd, H. Derendorf, M.E. Brewster, R.A. Baughman
    Pharmaceutical Biotechnology: A new graduate course at the University of Florida College of Pharmacy.
    Am. J. Pharm. Educ. 54, 46-50 (1990).
  60. J. Limberg, M. LeBel, H. Derendorf
    Evaluation of free tissue concentrations of fleroxacin after oral administration.
    Pharm. Res. 7, 422-424 (1990).
  61. E. Brunt, J. Limberg, H. Derendorf
    High performance liquid chromatographic-assay and erythrocyte partitioning of fleroxacin, a new fluoroquinolon antibiotic.
    J. Pharm. Biomed. Anal. 8, 67-71 (1990).
  62. H. Derendorf, H. Möllmann, J. Barth
    Comparative pharmacokinetic evaluation of glucocorticoids after intraarticular administration.
    Akt. Rheumatol. 15, 145-153 (1990).
  63. F.F.T. Ververs, H.G. Schaefer, J.F. Lefevre, L.M. Lopez, H. Derendorf
    Simultaneous HPLC-assay of propranolol, diltiazem and diltiazem-metabolites in human plasma with application.
    J. Pharm. Biomed. Anal. 8, 535-539 (1990).
  64. P. Adland-Davenport, M.P. Brown, J.D. Robinson, H. Derendorf
    Pharmacokinetics of amikacin in critically ill neonatal foals treated for presumed or confirmed sepsis.
    Equine Vet. J. 22, 18-22 (1990).
  65. H. Derendorf, H. Möllmann, G. Voortman, F.A. van den Ouweland, L.B.A. van de Putte, G. Gevers, J. Dequeker, E. van Vliet-Daskalopoulou
    Pharmacokinetics of rimexolone after intra-articular administration.
    J. Clin. Pharmacol. 30, 476-479 (1990).
  66. K. Dietzel, V. Keuth, K.S. Estes, M.E. Brewster, R. Clemmons, R. Vistelle, N.S. Bodor, H. Derendorf
    A redox-based system that enhances delivery of estradiol to the brain: Pharmacokinetic evaluation in the dog.
    Pharm. Res. 7, 879-883 (1990).
  67. H.G. Schaefer, H. Spahn, L.M. Lopez, H. Derendorf
    Simultaneous determination of propranolol and 4-hydroxypropranolol enantiomers after chiral derivatization using reversed phase high-performance liquid chromatography.
    J. Chromatogr. 527, 351-359 (1990).
  68. J. Limberg, D. Harrison, M.P. Hocking, H. Derendorf
    Theophylline absorption and gastric emptying after partial gastrectomy in dogs.
    J. Pharm. Sci. 79, 968-969 (1990).
  69. M. Kaltenbach, S.H. Curry, H. Derendorf
    Extent of drug absorption at the time of peak plasma concentration in an open one-compartment body model with first-order absorption.
    J. Pharm. Sci. 79, 462 (1990).
  70. K. Dietzel, K.S. Estes, M.E. Brewster, N.S. Bodor, H. Derendorf
    The use of hydroxypropyl-b-cyclodextrin as a vehicle for intravenous administration of dexamethasone in dogs.
    Int. J. Pharm. 59, 225-230 (1990).
  71. J. Barth, H. Fett, M. Pörtner, B.E. Braun, H. Möllmann, P. Rohdewald, J. Krämer, H. Derendorf
    Exogenous and endogenous glucocorticoid levels after epidural administration of glucocorticoid crystal suspensions in different volumes.
    Orthop. Praxis 26, 729-736 (1990).
  72. H. Möllmann, B. Armbruster, J. Barth, H. Derendorf, O.W. Flörke, G. Hochhaus, C.R. Möllmann, P. Rohdewald, E.W. Schmidt
    Distribution and aggregation of crystals in glucocorticoid suspensions.
    Akt. Rheumatol. 15, 101-124 (1990).
  73. C.D. Hepler, L.M. Strand, H. Derendorf
    The pharmacist and pharmaceutical care - future opportunities and responsibility.
    Pharmazeutische Zeitung 135, 3087-3092 (1990).
  74. K.S. Estes, V. Keuth, K. Dietzel, M.E. Brewster, N.S. Bodor, H. Derendorf
    A redox-based chemical delivery system that enhances estradiol to the brain: Disposition studies in the rat.
    Pharm. Res.8, 1180-1185 (1991).
  75. O. Makil, M. Kaltenbach, J. Limberg, D. Harrison, M.P. Hocking, H. Derendorf
    Pharmacokinetics of ranitidine after partial gastrectomy in dogs.
    J. Pharm. Sci. 80, 1034-1036 (1991).
  76. H. Derendorf, H. Möllmann, J. Barth, C. Möllmann, S. Tunn, M. Krieg
    Pharmacokinetics and oral bioavailability of hydrocortisone.
    J. Clin. Pharmacol. 31, 473-476 (1991).
  77. H. Möllmann, J. Barth, C. Möllmann, S. Tunn, M. Krieg, H. Derendorf
    Pharmacokinetics and rectal bioavailability of hydrocortisone acetate.
    J. Pharm. Sci. 80, 835-836 (1991).
  78. H. Derendorf, H. Möllmann, M. Krieg, S. Tunn, C. Möllmann, J. Barth, H.J. Röthig
    Pharmacodynamics of methylprednisolone phosphate after single intravenous administration to healthy volunteers.
    Pharm. Res. 8, 263-268 (1991).
  79. B. Wichert, H. Schreier, H. Derendorf
    Sensitive HPLC-assay for the determination of amikacin in human plasma.
    J. Pharm. Biomed. Anal. 9, 251-254(1991).
  80. C.D. Page, M. Mautino, H. Derendorf, W. Mechlinski
    Multiple-dose pharmacokinetics of ketoconazole administered orally to gopher tortoises (Gopherus polyphemus).
    J. Zoo & Wildlife Med. 22, 191-198 (1991).
  81. T. Loftsson, M.E. Brewster, H. Derendorf, N. Bodor
    2-Hydroxypropyl-b-cyclodextrin: Properties and usage in pharmaceutical formulations.
    PZ Wissenschaft 4, 5-10 (1991).
  82. C.D. Page, M. Mautino, H. Derendorf, J.P. Anhalt
    Comparative pharmacokinetics of trimethoprim-sulfamethoxazole administered intravenously and orally to captive elephants.
    J. Zoo & Wildlife Med. 22, 409-416 (1991).
  83. K.H. Rand, K. Gibbs, H. Derendorf, J. Graham-Pole
    Pharmacokinetics of intravenous immunoglobulin in bone marrow transplant patients.
    J. Clin. Pharmacol.31, 1151-1154 (1991).
  84. K.S. Estes, P. Dewland, M.E. Brewster, H. Derendorf, N. Bodor
    A redox-based chemical delivery system (CDS) applied to estradiol.
    PZ Wissenschaft 4, 153-158 (1991).
  85. G. Hochhaus, H. Derendorf, H. Möllmann, J. Barth
    A selective HPLC/RIA for dexamethasone and its prodrug dexamethasone-21-isonicotinate in biological fluids.
    J. Pharm. Biomed. Anal.9, 761-767 (1991).
  86. M.A. Longer, H.G. Schaefer, H. Derendorf
    Fundamentals of assessing bioequivalence studies.
    PZ Wissenschaft 5, 15-22 (1992).
  87. G. Hochhaus, L.S. Chen, A. Ratka, P. Druzgala, J. Howes, N. Bodor, H. Derendorf
    Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs.
    J. Pharm. Sci. 81, 1210-1215 (1992).
  88. H. Schreier, K.J. McNicol, M. Ausborn, D.M. Soucy, H. Derendorf, A.A. Stecenko, R.J. Gonzalez-Rothi
    Pulmonary delivery of amikacin liposomes and acute liposome toxicity in the sheep.
    Int. J. Pharmac. 87, 183-193 (1992).
  89. S. Tunn, H. Möllmann, J. Barth, H. Derendorf, M. Krieg
    Simultaneous measurement of cortisol in serum and saliva after different forms of cortisol administration.
    Clin. Chem. 38, 1491-1494 (1992).
  90. G. Hochhaus, R. Hochhaus, G. Werber, H. Derendorf, H. Möllmann
    A selective HPLC/RIA for dexamethasone and its prodrug dexamethasone-21-sulphobenzoate sodium in biological fluids
    Biomedical Chromatography 6, 283-286 (1992).
  91. H. Möllmann, H. Derendorf, J. Barth, C. Möllmann, S. Tunn, M. Krieg
    Bioavailability of hydrocortisone after rectal administration of hydrocortisone acetate foam.
    Med. Welt 43, 609-615 (1992).
  92. H. Derendorf
    Choice of appropriate pharmacokinetic-pharmacodynamic models for predicting drug effects.
    Klin. Pharmakol. aktuell 3, 19-21 (1992).
  93. J. Barth, M. Damoiseaux, H. Möllmann, K.H. Brandis, G. Hochhaus, H. Derendorf
    Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration.
    Int. J. Clin. Pharmacol. Ther. Toxicol. 30, 317-324 (1992).
  94. S. Mohammed, M. Butschkau, H. Derendorf
    A reversed phase liquid chromatographic method for the determination of codeine in biological fluids with application.
    J. Liq. Chromatogr. 16, 2325-2334 (1993).
  95. H. Derendorf, G. Hochhaus, H. Möllmann, J. Barth, M. Krieg, S. Tunn, C. Möllmann
    Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids.
    J. Clin. Pharmacol. 33, 115-123 (1993).
  96. T. Wagner, J. Barth, A. Tromm, C. Bigalke, S. Tunn, M. Krieg, H. Derendorf, H. Möllmann, B. May, G. Hochhaus
    Bioavailability of hydrocortisone after single and multiple dosing of hydrocortisone acetate foam in patients with chronic distal inflammatory bowel disease and healthy controls
    Akt. Koloproktol. 10, 223-226 (1993).
  97. S.S. Mohammed, M. Christopher, P. Mehta, A. Kedar, S. Gross, H. Derendorf
    Increased erythrocyte and protein binding of codeine in patients with sickle cell disease
    J. Pharm. Sci 82, 1112-1117 (1993).
  98. S.S. Mohammed, M. Ayass, P. Mehta, A. Kedar, S. Gross, H. Derendorf
    Codeine disposition in sickle cell patients compared with healthy volunteers
    J. Clin. Pharmacol. 33, 811-815 (1993).
  99. J. Barth, G. Hochhaus, H. Derendorf, K.H. Lehr, T. Hoehler, H. Möllmann
    Prednicarbate after different forms of administration: plasma levels of drug and metabolites and effects on endogenous cortisol levels in humans
    Curr. Probl. Dermatol. 21, 147-156 (1993).
  100. J. Barth, K.H. Lehr, H. Derendorf, H. Möllmann, T. Höhler, G. Hochhaus
    Studies on the pharmacokinetics and metabolism of prednicarbate after cutaneous and oral administration.
    Skin Pharmacol. 6, 179-186 (1993).
  101. J. Barth, H. Möllmann, B. Armbruster, W. Flörke, G. Hochhaus, C. Möllmann, H. Derendorf
    Analysis of shape, particle size, distribution and aggregation of the crystals of sodium cromoglycate and nedocromil sodium
    Eur. J. Hosp. Pharm. 3, 20-28 (1993).
  102. H. Möllmann, G. Hochhaus, A. Tromm, J. Barth, C. Bigalke, B. May, A. Möllmann, U. Schwegler, H. Derendorf, S. Tunn, M. Krieg
    Topical use of steroids in gastroenterology
    In "Inflammatory Bowel Diseases", ed. by J. Schölmerich, W. Kruis, H. Goebell, W. Hohenberger and V. Gross, pg. 343-349, Kluwer Academic Publishers, Dordrecht (1993).
  103. M.L. Kaltenbach, S.S.Mohammed, G. Mullersmann, J.H. Perrin, H. Derendorf
    Pharmacokinetic evaluation of two ibuprofen-codeine combinations
    Int. J. Clin. Pharmacol. Ther. 32, 210-214 (1994).
  104. G.N. Henderson, P.O. Whalen, R.A. Darr, S.H. Curry, H. Derendorf, T.G. Baumgartner, P.W. Stacpoole
    Development of an oral drug formulation for dichloroacetate and thiamine
    Drug Developm. Ind. Pharm. 20, 2425-2437 (1994).
  105. H. Derendorf
    Pharmacokinetic/pharmacodynamic consequences of space flight
    J. Clin. Pharmacol. 34, 684-691 (1994).
  106. H. Schreier, K.J. McNicol, D.B. Bennett, Z. Teitelbaum, H. Derendorf
    Pharmacokinetics of detirelix following intratracheal instillation and aerosol inhalation in the unanesthetized awake sheep
    Pharm. Res. 11, 1056-1059 (1994).
  107. A. Nolting, H. Derendorf
    Pharmacokinetic Profile: Ceftazidime
    Antiinf. Drugs Chemoth. 12, 31-35 (1994).
  108. R. Mies, J. van der Aa, C. Dixon, M. Kaltenbach, H. Derendorf, N. Gravenstein
    Computer-modulated patient-controlled analgesia: Preliminary evaluation of a prototype
    Regional Anesthesia 19, 270-276 (1994).
  109. H. Derendorf
    Pharmacodynamic aspects of systemic drug delivery
    Drug Developm. Ind. Pharm. 20, 485-502 (1994).
  110. J. Barth, H. Möllmann, T. Wagner, G. Hochhaus, H. Derendorf
    The validity of ‘equivalent doses’ in corticosteroid therapy - a comparison of the clinical pharmacokinetics and pharmacodynamics of prednisolone and methylprednisolone
    Dtsch. Med. Wschr. 119, 1671-1676 (1994).
  111. H. Schreier, J. Engel, K.J. McNicol, H. Derendorf, K. Groot, A.V. Schally
    Systemic delivery of the luteinizing hormone-releasing hormone (LH-RH) antagonist cetrorelix (SB-75) via pulmonary instillation in the unanesthetized awake sheep
    Eur. J. Pharm. Sci. 2, 303-306 (1994).
  112. G. Hochhaus, R.J. Gonzalez-Rothi, A. Lukyanov, H. Derendorf, H. Schreier, T. Dalla Costa
    Assessment of glucocorticoid lung targeting by ex-vivo receptor binding studies in rats
    Pharm. Res. 12, 134-137 (1995).
  113. H. Möllmann, S. Balbach, G. Hochhaus, J. Barth, H. Derendorf
    Pharmacokinetic-pharmacodynamic correlations of corticosteroids
    In "Handbook of pharmacokinetic-pharmacodynamic correlations", ed. by H. Derendorf and G. Hochhaus, CRC Press, Boca Raton, 323-362 (1995).
  114. A. Nolting, H. Derendorf
    Pharmacokinetic-pharmacodynamic modeling of antibiotics
    In "Handbook of pharmacokinetic-pharmacodynamic correlations", ed. by H. Derendorf and G. Hochhaus, CRC Press, Boca Raton, 363-388 (1995).
  115. G. Hochhaus, H. Derendorf
    Dose optimization based on pharmacokinetic-pharmacodynamic modeling
    In "Handbook of pharmacokinetic-pharmacodynamic correlations", ed. by H. Derendorf and G. Hochhaus, CRC Press, Boca Raton, 79-120 (1995).
  116. H. Derendorf, G. Hochhaus, S. Rohatagi, H. Möllmann, J. Barth, H. Sourgens, M. Erdmann
    Pharmacokinetics of triamcinolone acetonide after intravenous, oral and inhaled administration
    J. Clin. Pharmacol. 35, 302-305 (1995).
  117. H. Möllmann, G. Hochhaus, S. Rohatagi, J. Barth, H. Derendorf
    Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone
    Pharm. Res. 12, 1096-1100 (1995).
  118. L.B. Panton, G.J. Guillen, L. Williams, J.E. Graves, C. Vivas, M. Cediel, M.L. Pollock, L. Garzarella, J. Krumerman, H. Derendorf, D.T. Lowenthal
    The lack of effect of aerobic exercise training on propranolol pharmacokinetics in young and elderly adults
    J. Clin. Pharmacol. 35, 885-894 (1995).
  119. A. Nolting, H. Derendorf
    Pharmacokinetic Profile: Ceftriaxone
    Antiinf. Drugs Chemoth. 13, 27-31 (1995).
  120. S. Rohatagi, G. Hochhaus, H. Möllmann, J Barth and H. Derendorf
    Pharmacokinetic interaction between endogenous cortisol and exogenous corticosteroids
    Die Pharmazie, 50, 610-613 (1995).
  121. S. Rohatagi, G. Hochhaus, H. Möllmann, J. Barth, E. Galia, M. Erdmann, H. Sourgens, H. Derendorf
    Pharmacokinetic/pharmacodynamic evaluation of triamcinolone acetonide after intravenous, oral and inhaled administration
    J. Clin. Pharmacol. 35, 1187-1193 (1995).
  122. S. Rohatagi, U. Täuber, K. Richter, H. Derendorf
    Pharmacokinetic/pharmacodynamic modeling of cortisol suppression after oral administration of fluocortolone
    J. Clin. Pharmacol. 36, 311-314 (1996).
  123. S. Rohatagi, A. Bye, A. Mackie, H. Derendorf
    Mathematical modeling of cortisol circadian rhythm and cortisol suppression
    Eur. J. Pharm. Sci., 4, 341-350(1996).
  124. T. Dalla Costa, H. Derendorf
    AUIC - a general target for the optimization of dosing regimens of antibiotics?
    Ann. Pharmacother. 30, 1024-1028 (1996).
  125. H. Möllmann, G. Hochhaus, S. Rohatagi, J. Barth, H. Derendorf, M. Krieg, H. Weisser, A. Möllmann
    Pharmacokinetics and pharmacodynamics of cloprednol
    Int. J. Clin. Pharmacol. Ther. 34, 1-5 (1996).
  126. H. Möllmann, M. Wagner, H. Derendorf, M. Schulz
    Fluticasone, a new corticosteroid for inhalation
    Pharm. Ztg., 141:3662-3667(1996).
  127. A. Kovar, C. Schäfer, H. Derendorf
    Pharmacokinetic Profile: Cefepime
    Antiinf. Drugs Chemoth., 95-103(1996).
  128. A. Nolting, T. Dalla Costa, R. Vistelle, K.H. Rand, H. Derendorf
    Determination of free extracellular concentrations of piperacillin by microdialysis
    J. Pharm. Sci. 85, 369-372 (1996).
  129. A. Nolting, T. Dalla Costa, K.H. Rand, H. Derendorf
    Pharmacokinetic-pharmacodynamic modelling of the antibiotic effect of piperacillin
    Pharm. Res. 13, 91-96 (1996).
  130. H.Derendorf, T. Dalla Costa, Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairment, Int. J. Clin. Pharmacol. Ther. 34,482-488(1996).
  131. H. Möllmann, J. Barth, G. Hochhaus, A. Möllmann, H. Derendorf, A. Tromm
    Concepts of corticosteroid therapy of chronic inflammatory bowel disease: topical vs. systemic administration
    In "Corticosteroid therapy of chronic inflammatory bowel disease", ed. by B. May and H. Möllmann, Falk Foundation, 69-90 (1996).
  132. G. Hochhaus, H. Derendorf, H. Möllmann, J. Barth, R. Hochhaus
    Pharmacodynamic aspects of corticosteroid effects
    In "Corticosteroid therapy of chronic inflammatory bowel disease", ed. by B. May and H. Möllmann, Falk Foundation, 91-117 (1996).
  133. H. Derendorf, H. Möllmann, G. Hochhaus, J. Barth
    Kinetic/dynamic interrelationships as basis for rational therapy
    In "Corticosteroid therapy of chronic inflammatory bowel disease", ed. by B. May and H. Möllmann, Falk Foundation, 119-135 (1996).
  134. H. Möllmann, G. Hochhaus, A. Tromm, P. Froehlich, A. Möllmann, M. Krieg, H. Weisser, H. Derendorf, J. Barth
    Pharmacokinetics and pharmacodynamics of budesonide-pH-modified release capsules
    In "Corticosteroid therapy of chronic inflammatory bowel disease",
    ed. by B. May and H. Möllmann, Falk Foundation, 149-167 (1996).
  135. R. Gonzalez-Rothi, S. Suarez, G. Hochhaus, H. Schreier, A. Lukyanov, H. Derendorf, T. Dalla Costa
    Pulmonary targeting of liposomal triamcinolone acetonide phosphate
    Pharm. Res. 13, 1699-1703(1996).
  136. B.G. Danielson, T. Salmonson, H. Derendorf, P. Geisser
    Pharmacokinetics of iron (III)-hydroxide sucrose complex after a single i.v. dose in healthy volunteers
    Arzneimittelforschung (Drug Research) 46, 615-621(1996).
  137. A. Suri, M. Kaltenbach, B. Grundy, H. Derendorf
    Pharmacodynamic evaluation of codeine using tooth pulp evoked potentials
    J. Clin. Pharmacol. 36, 1126-1131 (1996).
  138. S. Rohatagi, A. Bye, C. Falcoz, A. Mackie, B. Meibohm, H. Möllmann, H. Derendorf
    Dynamic modeling of cortisol reduction after inhaled administration of fluticasone propionate,
    J. Clin. Pharmacol., 36:938-941(1996).
  139. H. Möllmann, J. Barth, G. Hochhaus, A. Möllmann, H. Derendorf, A. Tromm
    Principles of topical versus systemic corticoid treatment in inflammatory bowel disease
    in ‘Glucocorticoid Therapy in Chronic Inflammatory Bowel Disease’, ed. by H. Möllmann and B. May, Kluwer, 42-60 (1996).
  140. G. Hochhaus, H. Derendorf, H. Möllmann, J. Barth, R. Hochhaus
    Pharmacodynamic aspects of glucocorticoid action
    in ‘Glucocorticoid Therapy in Chronic Inflammatory Bowel Disease, ed. by H. Möllmann and B. May, Kluwer, 61-79 (1996).
  141. H. Derendorf, H. Möllmann, G. Hochhaus, J. Barth
    Kinetic/dynamic interrelationships as basis for rational therapy
    in ‘Glucocorticoid Therapy in Chronic Inflammatory Bowel Disease’, ed. by H. Möllmann and B. May, Kluwer, 80-98 (1996).
  142. H. Möllmann, G. Hochhaus, A. Tromm, P. Froehlich, A. Möllmann, M. Krieg, H. Weisser, H. Derendorf, J. Barth
    Pharmacokinetics and pharmacodynamics of budesonide pH-modified release capsules
    in ‘Glucocorticoid Therapy in Chronic Inflammatory Bowel Disease’, ed. by H. Möllmann and B. May, Kluwer, 107-120 (1996).
  143. A. Suri, B. Grundy, H. Derendorf
    Pharmacokinetics and pharmacodynamics of enantiomers of ibuprofen and flurbiprofen after oral administration
    Int. J. Clin. Pharm. Ther. 35, 1-8 (1997).
  144. H. Sourgens, H. Derendorf, H. Schifferer
    Pharmacokinetic profile of cefaclor
    Int. J. Clin. Pharmacol. Ther. 35, 374-380 (1997).
  145. A. Suri, K.S. Estes, G. Geisslinger, H. Derendorf
    Pharmacokinetic-pharmacodynamic relationships for analgesics
    Int. J. Clin. Pharmacol. Ther. 35, 307-323 (1997).
  146. M. Brewster, W. Anderson, A. Webb, L.M. Pablo, D. Meinsma, D. Moreno, H. Derendorf, N. Bodor, E. Pop
    Evaluation of a brain-targeting zidovudine chemical delivery system in dogs
    Antimicrob. Agents Chemother. 41, 122-128 (1997).
  147. A. Kovar, A. Nolting, H. Derendorf
    Microdialysis for the determination of unbound tissue concentrations (in German)
    PharmUZ 26, 17-23 (1997).
  148. A. Kovar, T. Dalla Costa, H. Derendorf
    Comparison of plasma and free tissue levels of ceftriaxone in rats using microdialysis
    J. Pharm. Sci. 86, 52-56 (1997).
  149. G.N. Henderson, S.H. Curry, H. Derendorf, E.C. Wright, P.W. Stacpoole
    Pharmacokinetics of dichloroacetate in adult patients with lactic acidosis
    J. Clin. Pharmacol. 37, 416-425 (1997).
  150. M.E. Brewster, W.R. Anderson, D. Meinsma, D. Moreno, A.I. Webb, L. Pablo, K.S. Estes, H. Derendorf, N. Bodor, R. Sawchuk, B. Cheung, E. Pop
    Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-b-cyclodextrin-based formulation of carbamazepine in the dog: Comparison with commercially available tablets and suspensions
    J. Pharm. Sci. 86, 335-339 (1997).
  151. B. Meibohm, H. Derendorf
    Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modeling
    Int. J. Clin. Pharmacol. Ther. 35, 401-413 (1997).
  152. T. Dalla Costa, A. Nolting, K. Rand, H. Derendorf
    Pharmacokinetic-pharmacodynamic modeling of the in-vitro antiinfective effect of piperacillin-tazobactam combinations
    Int. J. Clin. Pharmacol. Ther. 35, 426-433 (1997).
  153. H. Derendorf, H. Möllmann, G. Hochhaus, B. Meibohm, J. Barth
    Clinical PK/PD modelimg as a tool in drug development of corticosteroids
    Int. J. Clin. Pharmacol. Ther. 35, 481-488 (1997).
  154. B. Meibohm, G. Hochhaus, S. Rohatagi, H. Möllmann, J. Barth, M. Wagner, M. Krieg, R. Stöckmann, H. Derendorf
    Dependency of cortisol suppression on the administration time of inhaled corticosteroids
    J. Clin. Pharmacol. 37, 704-710 (1997).
  155. S. Rohatagi, S. Kan, H. Derendorf
    Non-compartmental analysis of pharmacokinetic data after multiple intravenous and oral administration
    Pharmazie 52, 529-532 (1997).
  156. G. Hochhaus, H. Möllmann, H. Derendorf, R.J. Gonzalez-Rothi
    Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model
    J. Clin. Pharmacol. 37, 881-892 (1997).
  157. H. Möllmann, H. Derendorf, J. Barth, B. Meibohm, M. Wagner, M. Krieg, H. Weisser, J. Knöller, A. Möllmann, G. Hochhaus
    Pharmacokinetic/pharmacodynamic evaluation of systemic effects of flunisolide after inhalation
    J. Clin. Pharmacol. 37, 893-903 (1997).
  158. A. Kovar, H. Derendorf
    Plasma and free tissue concentrations – significance for the evaluation of antibiotics (in German)
    Krankenhauspharmazie 18, 564-567 (1997).
  159. S. Rohatagi, J. Barth, H. Möllmann, G. Hochhaus, A. Soldner, C. Möllmann, H. Derendorf
    Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral dosing
    J. Clin. Pharmacol. 37, 916-925 (1997).
  160. M. Müller, B. Rohde, A. Kovar, A. Georgopoulos, H.G. Eichler, H. Derendorf
    Relationship between plasma and free interstitial concentrations of cefodizime and cefpirome in muscle and subcutaneous adipose tissue of healthy volunteers measured by microdialysis
    J. Clin. Pharmacol. 37, 1108-1113 (1997).
  161. H. Derendorf
    Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety
    Resp. Med. 91A, 22-28 (1997).
  162. G. Hochhaus, P. Froehlich, R. Hochhaus, A. Möllmann, H. Derendorf, J. Barth, H. Möllmann
    A selective HPLC/RIA for the determination of budesonide
    J. Pharm. Biomed. Anal., 17, 1235-1242(1998).
  163. H. Derendorf, G. Hochhaus
    Pharmacodynamic aspects of drug delivery
    Klin. Pharmakol. 15, 10-18 (1998).
  164. H. Möllmann, M. Wagner, B. Meibohm, G. Hochhaus, J. Barth, R. Stöckmann, M. Krieg, H. Weisser, C. Falcoz, H. Derendorf
    Pharmacokinetic and pharmacodynamic evaluation of fluticasone after inhaled administration
    Eur. J. Clin. Pharmacol. 53, 459-467 (1998).
  165. D. Gravenstein, A. Suri, H. Derendorf, J. Koska
    Influence of plasma expansion on plasma protein binding of ketorolac
    J. Clin. Anesthes., 10, 464-468(1998)..
  166. H. Derendorf, G. Hochhaus, B. Meibohm, H. Möllmann, J. Barth
    Pharmacokinetics and pharmacodynamics of inhaled corticosteroids
    J. Allergy Clin. Immunol. 101, S440-446 (1998).
  167. E. Liang, H. Derendorf
    Pitfalls in pharmacokinetic multi-compartmental analysis
    J. Biopharm. Pharmacokin., 26, 247-260(1998)..
  168. S.A. Lottenberg, D. Gianella-Neto, H. Derendorf, M. Rocha, A. Bosco, S.V. Carvalho, A.E. Moretti, A.C. Lerario, B.L. Wajchenberg
    Effect of fat distribution on the pharmacokinetics of cortisol in obesity
    Int. J. Clin. Pharm. Ther., 36, 501-505(1998)..
  169. B. Meibohm, H. Möllmann, M. Wagner, G. Hochhaus, A. Möllmann, H. Derendorf
    The clinical pharmacology of fluticasone propionate
    Rev. Contemp. Pharmacother. 8, 535-549 (1998).
  170. A. Hämmerlein, H. Derendorf, D. Lowenthal
    Pharmacokinetic and pharmacodynamic changes in the elderly – clinical implications
    Clin. Pharmacokin. 35, 49-64 (1998)
  171. H. Sourgens, R. Hoerr, A. Biber, H. Steinbrede, H. Derendorf
    KA 672-HCl, a neuronal activator against dementia: Tolerability, safety and preliminary pharmacokinetics after single and multiple oral doses in healthy male and female volunteers
    J. Clin. Pharm. 38, 373-381 (1998).
  172. T. Dalla Costa, A. Nolting, A. Kovar, H. Derendorf
    Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis
    J. Antimicrob. Chemother., 42, 769-778(1998).
  173. H. Möllmann, M. Wagner, J. Barth, H. Derendof, M. Schulz
    Broncholytics/Antiasthmatics - Fluticasone
    In "Offizin und Praxis 16/17", ed. by H. Morck, H. Liekfeld, L. Schneider, Govi-Verlag, 105-113 (1998)
  174. S. Modric, A. Webb, H. Derendorf
    Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle
    J. Vet. Pharmacol. Ther. 21, 444-452 (1998)
  175. M. Wagner, R. Stöckmann, AC Möllmann, g. Hochhaus, H Derendorf, J. Barth, H. Möllmann
    fluticasone propionate: First long-acting inhaled corticosteroid
    Atemwegs- und Lungenerkrank., accepted for publication 1999
  176. H. Derendorf, A. Kovar
    Tissue kinetics of b-lactam antibiotics
    Antiinf. Drugs Chemother., accepted for publication 1999.
  177. B. Meibohm, G. Hochhaus, H. Möllmann, J. Barth, M. Wagner, M. Krieg, R. Stöckmann, H. Derendorf
    A PK/PD approach to predict the cumulative cortisol suppression of inhaled corticosteroids
    J. Biopharm. Pharmacokin., accepted for publication.
  178. E.U. Graefe, H. Derendorf, M. Veit
    Pharmacokinetics and bioavailability of the flavonol quercetin in humans
    Int. J. Clin. Pharmacol. Ther., 37, 209-218(1999)
  179. I. Beierle, B. Meibohm, H. Derendorf
    Gender differences in pharmacokinetics and pharmacodynamics
    Int. J. Clin. Pharmacol. Ther. 37, 529-547(1999)
  180. B. Mayer, C. Mensik, S. Krishnaswami, H. Derendorf, H.G. Eichler, L. Schmetterer, M. Wolzt
    Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans
    J. Clin. Pharm., 47, 539-544(1999)
  181. B. Meibohm, H. Derendorf, H. Möllmann, M. Wagner, P. Froehlich, G. Hochhaus
    Physiologically based PK/PD –model for the interaction between endogenous and exogenous corticosteroids and blood lymphocytes
    J. Clin. Pharmacol., 37, 367-376(1999)
  182. H. Derendorf, B. Meibohm
    Modeling of pharmacokinetic/pharmacokinetic (Pharmacokinetic/Pharmacodynamic) relationships: Concepts and perspectives
    Pharm. Res., 16, 176-185(1999)
  183. A. de la Peña, H. Derendorf
    Pharmacokinetic properties of beta-lactamase inhibitors
    Int. J. Clin. Pharmacol. Ther., 37, 63-75(1999)
  184. D.H. Schweitzer, P.P.H. LeBrun, S. Krishnaswami, H. Derendorf,
    Pharmacodynamic effects of an accidental triamcinolone acetonide overdose – a case study
    Neth. J. Med. 56, 12-16 (2000).
  185. M. Schwahn, N.V. Nagaraja, H. Derendorf
    Population pharmacokinetic modeling of cetrorelix, a novel LH-RH antagonist, and testosterone in rats and dogs
    Pharm. Res. 17, 328-335(2000)
  186. B. Pechstein, N.V. Nagaraja, R. Hermann, P. Romeis, M. Locher, H. Derendorf
    Pharmacokinetic-pharmacodynamic modeling of testosterone and luteinizing hormone suppression by cetrorelix in healthy volunteers J. Clin. Pharmacol. 40, 266-274 (2000).
  187. A. de la Peña, A. Gräbe, H. Derendorf
    Pharmacokinetics of beta-lactamase inhibitors in renal impairment (in German)
    Chemotherapy J. 9, 107-113 (2000).
  188. S. Delacher, H. Derendorf, U. Hollenstein, M. Brunner, C. Joukhadar, S. Hofmann, A. Georgopolos, H.G. Eichler, M. Müller
    A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans
    J. Antimicrob. Chemother. 46, 733-739(2000)
  189. H. Derendorf, L.J. Lesko, P. Chaikin, W.A. Colburn, P. Lee, R. Miller, R. Powell, G. Rhodes, D. Stanski, J. Venitz
    Pharmacokinetic/pharmacodynamic modeling in drug research and development
    J. Clin. Pharmacol., 40, 1399-1418(2000).
  190. H. Derendorf, G. Hochhaus, S. Krishnaswami, B. Meibohm, H. Möllmann
    Optimized therapeutic ratio of inhaled corticosteroids using retrometabolism
    Pharmazie 55, 223-227 (2000).
  191. S. Krishnaswami, H. Möllmann, H. Derendorf, G. Hochhaus
    A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma
    J. Pharm. Biomed. Anal. 22, 123-129 (2000).
  192. N.V. Nagaraja, Y.J. Park, S. Jeon, C.D. Sands, H. Derendorf
    Population pharmacokinetics of digoxin in Korean patients
    Int. J. Clin. Pharmacol. Ther. 38, 291-297 (2000).
  193. A. de la Peña, P. Liu, H. Derendorf
    Microdialysis in peripheral tissues
    Adv. Drug Deliv. Rev. 45, 189-216 (2000).
  194. G. Hochhaus, J. Barrett, H. Derendorf
    Evolution of pharmacokinetics and pharmacokinetic/dynamic correlations during the 20    th century
    J. Clin. Pharmacol. 40, 908-917 (2000).
  195. S. Krishnaswami, G. Hochhaus, H. Derendorf
    An interactive algorithm for the assessment of cumulative cortisol suppression during inhaled corticosteroid therapy
    AAPS Pharmsci. (http://www.pharmsci.org) 2(3), article 22 (2000).
  196. B. Meibohm, H. Derendorf
    Pharmacokinetics and pharmacodynamics of biotechnological drugs (in German)
    In "Pharmazeutische Biotechnologie", edited by O. Kayser and R.H. Müller, Wissenschaftliche Verlagsgesellschaft Stuttgart, p. 103-124 (2000).
  197. N.V. Nagaraja, B. Pechstein, K. Erb, C. Klipping, R. Hermann, G. Niebch, H. Derendorf
    PK/PD modeling of cetrorelix, a LH-RH anatgonist, after subcutaneous administration in healthy postmenopausal women
    Clin. Pharm. Ther. 68,617-625 (2000).
  198. A. Kovar, T. Peters, N. Beier, H. Derendorf
    Pharmacokinetic/pharmacodynamic evaluation of eniporide
    J. Clin. Pharmacol. 41, 139-148 (2001).
  199. G. Hochhaus, J. Barth, S. Al-Fayoumi, S. Suarez, H. Derendorf, H. Möllmann
    Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: A comparison with dexamethasone phosphate (DP)
    J. Clin. Pharmacol. 41, 425-434 (2001).
  200. H. Derendorf, G. Hochhaus, H. Möllmann
    Evaluation of pulmonary absorption using pharmacokinetic methods
    J. Aerosol Med. 14, S9-S18 (2001).
  201. S. Krishna, N.V. Nagaraja, T. Planche, T. Agbenyega, G. Bedo-Addo, D. Ansong, A. Owusu-Ofori, A. Shroads, G. Henderson, A. Hutson, H. Derendorf, P. Stacpoole
    Population pharmacokinetics of intramuskular quinine in children with severe malaria
    Antiinf. Agents Chemother., 45,1803-1809(2001)
  202. H. Möllmann, M. Wagner, S. Krishnaswami, H. Dimova, Y. Stöckmann, B. Barth, C. Lawlor, A. Möllmann, H. Derendorf, G. Hochhaus
    Single-dose and steady-state pharmacokientic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder
    J. Clin. Pharmacol. 41, 1329-1338(2001).
  203. H. Derendorf, P.T. Daley-Yates, J. Efthimiou
    Systemic bioavailability of inhaled steroids: The importance of appropriate and comparable methodology
    Eur. Resp. J. 17, 157-158 (2001).
  204. E.U. Gräfe, J. Wittig, S. Müller, A.K. Riethling, B. Uehleke, B. Drewelow, H. Pforte, G. Jacobasch, H. Derendorf, M. Veit
    Pharmacokinetics and bioavailability of quercetin glycosides in humans
    J. Clin. Pharmacol. 41, 492-499 (2001).
  205. A. Tromm, H. Möllmann, J. Barth, G. Hochhaus, M. Krieg, C. Bigalke, A. Möllmann, H. Derendorf
    Pharmacokinetics and rectal bioavailability of hydrocortisone acetate after single and multiple administration in healthy subjects and patients
    J. Clin. Pharmacol. 41, 536-541 (2001).
  206. C. Joukhadar, H. Derendorf, M. Müller
    Microdialysis - a novel tool for clinical studies of antiinfective agents
    Eur. J. Clin. Pharmacol. 57, 211-219 (2001).
  207. M. Müller, U. Müller-Zellenberg, G. Hochhaus, H. Derendorf
    Current concepts in pharmacokinetics and their implications for clinical medicine
    Wien. Klin. Wochenschr. 15/16, 566-572 (2001).
  208. A. de la Peña, T. Dalla Costa, J.D. Talton, E. Rehak, J. Gross, U. Thyroff-Friesinger, A.I. Webb, M. Müller, H. Derendorf
    Penetration of cefaclor into the interstitial space fluid of skleletal muscle and lung tissue in rats
    Pharm. Res. 18, 1310-1314 (2001).
  209. H. Derendorf, S. Krishnaswami, G. Hochhaus, H. Möllmann
    Systemic disposition and effects of inhaled corticosteroids
    In 'Airway activity and selectivity of inhaled steroids in asthma', ed. by R. Schleimer, P. O'Byrne, S. Szefler, R. Brattsand, Dekker, Lung biology in health and disease, Vol. 163, pg. 247-272 (2001).
  210. G. Hochhaus, H. Derendorf, J. Talton, H. Möllmann
    Factors involved in the pulmonary targeting of inhaled glucocorticoids
    In 'Airway activity and selectivity of inhaled steroids in asthma', ed. by R. Schleimer, P. O'Byrne, S. Szefler, R. Brattsand, Dekker, Lung biology in health and disease, Vol. 163, pg. 283-307 (2001).
  211. B. Meibohm, H. Derendorf
    Pharmacokinetic/pharmacodynamic studies in drug product development
    J. Pharm. Sci. 91, 18-31 (2002).
  212. H. Derendorf, P.T. Daley-Yates, L.N. Pierre, J. Efthimiou
    Bioavailability and metabolism of mometasone furoate - pharmacology versus methodology
    J. Clin. Pharmacol. 42, 383-387 (2002).
  213. A. de la Peña, M. Brunner, H.-G. Eichler, E. Rehak, J. Gross, U. Thyroff-Friesinger, M. Müller, H. Derendorf
    Comparative target site pharmacokinetics of immediate and modified-release formulations of cefaclor in humans
    J. Clin. Pharmacol. 42, 403-411 (2002).
  214. G. Hochhaus, S. Sahasranaman, H. Derendorf, H. Möllmann
    Intranasal glucocorticoid delivery: competition between local and systemic effects
    S.T.P. Pharma Sciences 12, 23-31 (2002).
  215. A. Buchwald, H. Derendorf, F. Ji, N.V. Nagaraja, M.W. Wu, N. Bodor
    Soft cannabinoid analogues as potential anti-glaucoma agents
    Pharmazie 57, 108-114 (2002).
  216. P. Liu, M. Müller, M. Grant, A. Webb, B. Obermann, H. Derendorf
    Interstitial tissue concentration of cefpodoxime
    J. Antimicrob. Chemother. 50, 19-22 (2002).
  217. B. Meibohm, I. Beierle, H. Derendorf
    How important are gender differences in pharmacokinetics
    Clin. Pharmacokinet. 41, 329-342 (2002).
  218. P. Liu, M. Müller, H. Derendorf
    Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations
    Int. J. Antimicrob. Agents 19, 285-290 (2002).
  219. J.W. Mouton, M.N. Dudley, O. Cars, H. Derendorf, G.L. Drusano
    Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs
    Int. J. Antimicrob. Agents 19, 355-358 (2002).
  220. C. Kohlert, G. Schindler, R.W. März, G. Abel, B. Brinkhaus, H. Derendorf, E.U. Gräfe, M. Veit
    Systemic availability and pharmacokinetics of thymol in humans
    J. Clin. Pharmacol. 42, 731-737 (2002).
  221. V.A. Bhattaram, E.U. Gräfe, C. Kohlert, M. Veit, H. Derendorf
    Pharmacokinetics and bioavailability of herbal medicinal products
    Phytomedicine, 9, 1-36 (2002).
  222. E. El Desoky, N.V. Nagaraja, H. Derendorf
    Population pharmacokinetics of digoxin in Egyptian children
    Am. J. Ther., 9, 4923-498 (2002).
  223. K. Erb, K. Junge, B. Pechstein, E. Schneider, H. Derendorf, R. Hermann
    Novel formulations of cetrorelix acetate in haelthy men: Pharmacodynamic effects and noncompartmental pharmacokinetics
    J. Clin. Pharmacol. 42, 995-1001 (2002).
  224. C. Rojas, N.V. Nagaraja, A.I. Webb, H. Derendorf
    Microdialysis of triamcinolone acetonide in rat muscle
    J. Pharm. Sci. 92, 394-397 (2003).
  225. N.V. Nagaraja, B. Pechstein, K. Erb, C. Klipping, R. Hermann, M. Locher, H. Derendorf
    PK/PD modeling of LH suppression and LH surge delay by cetrorelix after single and multiple doses in healthy premenopausal women
    J. Clin. Pharmacol., 43, 243-251 (2003).
  226. AM Persky, M. Müller, H. Derendorf, M. Grant, G. A. Brazeau and G. Hochhaus
    Single and multiple dose pharmacokinetics of oral creatine
    J Clin Pharmacol, 43, 29-37(2003).
  227. H. Sourgens, J. Schmidt, H. Derendorf
    Comparison of talinolol and atenolol effects on blood presure in relation to lipid and glucose metabolic parameters. Results from the TALIP study
    Int. J. Clin. Pharmacol. Ther. 41, 22-29 (2003).
  228. T. Agbenyega, T. Planche. G. Bedu-Addo, D. Ansong, A. Owusu-Ofori, V.A. Bhattaram, N.V. Nagaraja, A.L. Shroads, G.N. Henderson, A.D. Hutson, H. Derendorf, S. Krishna, P.W. Stacpoole
    Population kinetics, efficacy, and safety of dichloroacetate for lactic acidosis due to severe malaria in children
    J. Clin. Pharmacol. 43, 386-396 (2003).
  229. B. Meibohm, H. Derendorf
    Pharmacokinetics and pharmacodynamics of biotechnology products (in Polish)
    In "Biotechnologia Farmaceutyczna", edited by O. Kayser and R.H. Müller, Wydawnictwo Lekarskie PZWL Warszawa, p. 91-110 (2003).
  230. D.B. Allen, L. Bielrory, H. Derendorf, R. Dluhy, G.L. Colice, S.J. Szefler
    Inhaled corticosteroids: Past lessons and future issues
    Journal Allergy Clin. Immunol. 112, S1-40 (2003).
  231. A.M. Persky, N.D. Eddington, H. Derendorf
    A review of the effects of chronic exercise and physical fitness level on resting pharmacokinetics
    Int. J. Clin. Pharmacol. Ther. 41, 504-516 (2003).
  232. P. Liu, H. Derendorf
    Antimicrobial tissue concentrations
    Infect. Dis. Clin. N. Am. 17, 599-613 (2003).
  233. S. Rohatagi, S. Appajoyula, H. Derendorf, S. Szefler, R. Nave, K. Zech, D. Banerji
    Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective
    J. Clin. Pharmacol. 44, 37-47 (2004).
  234. A. de la Pena, A.Gräbe K. Rand, E. Rehak, J. Gross, U. Thyroff-Friesinger, Müller M, H. Derendorf
    PK-PD modeling of the effect of cefaclor on four different bacterial strains
    Int. J Antimicrob Agents 24,218-225(2004).
  235. B. Meibohm, H. Derendorf
    Pharmacokinetics and pharmacodynamics of biotech drugs In "Pharmaceutical Biotechnology", editred by O. Kayser and R.H. Müller, Wiley-VCH, Weinheim, p. 147-172 (2004).
  236. M. Müller, A. De la Pena, H. Derendorf
    Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: Kill curves versus MIC
    Antimicrob. Agents Chemother. 48,369-377(2004).
  237. R. Hermann, M. Locher, M. Siebert-Weigel, N. LaVallee, H. Derendorf, G. Hochhaus
    Intranasal loteprednol etabonate in healthy maile subjects: Pharmacokinetics and effects on endogenous cortisol
    J. Clin. Pharmacol. 44, 510-519 (2004)
  238. Q. Liu, K. Rand, H. Derendorf
    Impact of tazobactam pharmacokinetics on the antimicrobial effect of piperacillin-tazobactam combinations
    Int. J. antimicrob. Agents 23, 494-497(2004).
  239. H. Derendorf
    Relevant pharmacokinetic parameters for determining efficacy and safety in inhaled corticosteroids
    Eur Respir Rev 13, 62-65 (2004).
  240. A. Graebe, E.L. Schuck, P. Lensing, L. Putcha, H. Derendorf
    Physiological, pharmacokinetic and pharmacodynamic changes in space
    J. Clin. Pharmacol. 44, 837-853 (2004).
  241. M. Müller, A. de la Pena, H. Derendorf
    Issues in pharmacokinetics nad pharmacodynamics of anti-infective agents : Distribution in tissue
    Antimicrob. Agents Chemother. 48, 1441-1453 (2004).
  242. J. Winkler, G. Hochhaus, H. Derendorf
    How the lung handles durgs" Pharmacokinetics and pharmacodynamics of inhaled corticosteroids
    Proc. Am. Thorac. Soc. 1, 356-363 (2004).
  243. A. Schuck, I. Rinas, H. Derendorf
    In vitro microdialysis sampling of docetaxel
    J. Pharm. Biomed. Anal., 36, 807-813 (2004).
  244. K. Kim, J.A. Johnson, H. Derendorf
    Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms
    J. Clin. Pharmacol. 44, 1083-1105 (2004).
  245. J. Barth, J. Winkler, R. Schumann, N.V. Nagaraja, R. Madabushi, S. Balbach, H. Derendorf, H. Möllmann and G. Möllenhoff
    Population pharmacokinetics of methylprednisolone in accident victims with spinal cord injury
    I J Clin Pharmacol Therap. 42, 504-511 (2004).
  246. V. Butterweck, H. Derendorf, W. Gaus, A. Nahrstedt, V. Schulz, M.Unger
    Pharmacokinetic herb-drug interactions: Are preventive screenings necessary and appropriate?
    Planta Med 70, 784-791 (2004).
  247. H. Derendorf, S. Pedersen
    Choosing an inhaled corticosteroid for once-daily administration in asthma
    Resp. Dig. 6(2), 1-11 (2004).
  248. S.M. Wittemer, M. Ploch, T. Windeck, S.C. Müller, B. Drewelow, H. Derendorf, M. Veit
    Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans
    Phytomedicine 12, 28-38 (2005).
  249. V.A. Bhattaram, N.V. Nagaraja, T. Peters, T. Machnig, S. Kroesser, A. Kovar and H. Derendof
    Population Pharmacokinetics of Eniporide and Its Metabolite in Healthy Subjects and Patients With Acute Myocardial Infarction
    J Clin Pharmacol, 45, 631-639 (2005).
  250. S. Krishnaswami, G. Hochhaus, H. Möllmann, H. Derendorf
    Interpretation of absorption rate data for fluticasone propionate obtained in compartmental pharmacokinetic modeling
    Int.J Clin. Pharmacol. Ther. 43, 117-122 (2005).
  251. C. Buck, N. Bertram, T. Ackermann, T. Sauerbruch, H. Derendorf, W.D. Paar
    Pharmacokinetics of piperacillin-tazobactam: intermittent dosing versus continuous infusion
    Int. J Antimicrob. Agents 25, 62-67 (2005).
  252. O. Burkhardt, J. Majcher-Peszynska, K. Borner, R. Mundkowski, B. Drewelow, H. Derendorf, T. Welte
    Penetration of ertapenem into different pulmonary compartments of ptients undergoing lung surgery
    J. Clin. Pharmacol. 45, 659-665 (2005) .
  253. E.L. Schuck, A. Dalhoff, H. Stass, H. Derendorf, Pharmacokinetic/Pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form.
    Infection 33, 22-28 (2005).
  254. J. Mouton, M.N. Dudley, O. Cars, H. Derendorf, G.L. Drusano
    Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for antiinfective drugs: An update
    J. Antimicrob. Chemother. 55, 601-607 (2005) .
  255. P. Liu, K.H. Rand, B. Obermann, H. Derendorf
    Pharmacokinetic-pharmacodynamic modeling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models
    Int. J Antimicrob. Agents 25, 120-129 (2005).
  256. P. Liu, R. Fuhrherr, A.I. Webb, B. Obermann, H. Derendorf
    Tissue penetration of cefpodoxime into the skeletal muscle and lung in rats
    Eur. J. Pharm. Sci. 25 , 439-444 (2005).
  257. P. Liu, M. Müller, M. Grant, B. Obermann, H. Derendorf
    Tissue penetration of cefpodoxime and cefixime in healthy subjects
    J. Clin. Pharmacol. 45, 564-569 (2005).
  258. W.R. Heizmann and H. Derendorf
    Kriterien zur Abgrenzung der Kombinationen Piperacillin/Tazobactam und Piperacillin/Sulbactam
    Z. Herz-Thorax - Gefässchir, 19, 89-99 (2005).
  259. H. Derendorf, G. Hochhaus
    What is the best marker for inhaled corticosteroid safety?
    Allergy Asthma Proceed. 26, 89-94 (2005).
  260. E.L. Schuck, M. Grant, H. Derendorf
    Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers
    J. Clin. Pharmacol. 45, 822-831 (2005).
  261. H. Derendorf, C.P. Van der Maelen, R.S. Brickel, T.R. MacGregor, W. Eisert.
    Dipyridamole bioavailability in subjects with reduced gastric acidity
    J. Clin. Pharmacol. 45, 845-850 (2005).
  262. R.P.E.Yanong, E.W. Curtis, R. Simons, V.A. Bhattaram, M. Gopalakrishnan, N. Ketabi, N.V. Nagaraja and H. Derendorf
    Pharmacokinetic Studies of Florfenicol in Koi Carp and Threespot Gourami Trichogaster Trichopterus after Oral and Intramuscular Treatment
    J Aquatic Animal Health, 17, 129-137 (2005).
  263. E.L. Schuck, and H. Derendorf
    Pharmacokinetic/pharmacodynamic Evaluation of Anti-infective Agents
    Expert Rev. Anti infect. Ther., 3, 361-373 (2005).
  264. M. Hübner, G. Hochhaus, H. Derendorf Comparative pharmacology, bioavailability, pharmacokinetics and pharmacodynamics of inhaled glucocorticoids Immunol. Allergy Clin. N. Am. 25, 469-488 (2005).
  265. M. Brunner, H. Derendorf, M. Müller
    Microdialysis for in vivo pharmacokinetic/ pharmacodynamic characterization of anti-infective drugs
    Curr. Opin. Pharmacol. 5, 1-5 (2005).
  266. H. Derendorf Corticosteroid pharmacokinetic/pharmacodynamic parameters and their relationship to safety and efficacy Allergy Asthma Proceed. 26, 327-335 (2005).
  267. E. ElDesoky, R. MAdabushi, Sel D. Amry, V.A. Bhattaram, H. Derendorf
    Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense?
    Am. J. Ther. 12, 320-327 (2005).
  268. W.V. De Castro, S. Mertens-Talcott, A. Rubner, V. Butterweck, H. Derendorf,
    Variation of flavonoids and furanocoumarins in grapefruit juices: a potential source of variability in grapefruit juice-drug interaction studies,
    J. Agric. Food Chem. 11, 249-255 (2006).
  269. E. ElDesoky, H. Derendorf. U. Klotz,
    Variability in response to cardiovascular drugs,
    Curr. Clin. Pharmacol. 1, 35-46 (2006).
  270. O. Burkhardt, H. Derendorf, T. Welte
    Achieving eradication of MRSA colonization in patients. Therapeutic options
    Med. Monatsschr. Pharm. 29, 17-21 (2006).
  271. O. Burkhardt, H. Derendorf, T. Welte
    New antibiotics for the treatment of MRSA infections
    Med. Monatsschr. Pharm. 29, 56-62 (2006).
  272. S.U. Mertens-Talcott, I. Zdrojewski, W.V. Castro, V. Butterweck, H. Derendorf
    Drug interactions of grapefruit and other citrus – what have we learned?
    In Lam, Huang, Hall (Ed.), Herbal Supplement-Drug Interactions, Marcel Dekker (2006, in press).
  273. R. Madabushi, B. Frank, B. Drewelow, H. Derendorf, V. Butterweck
    Hyperforin in St. John’s wort drug interactions
    Eur. J. Clin. Pharmacokin. 62, 225-233 (2006).
  274. J.G. Stark, S. Werner, S. Homrighausen, Y. Tang, M. Krieg, H. Derendorf, H. Möllmann, G. Hochhaus
    Pharmacokinetic/pharmacodynamic modeling of total lymphocytes and selected subtypes after oral budesonide
    J. Pharmacokinet. Pharmacodyn. (2006).
  275. M.J. Salvador, E.O. Ferreira, S.U. Mertens-Talcott, W.V. De Castro, V. Butterweck, H. Derendorf, D.A. Dias
    Isolation and HPLC quantitative analysis of antioxidant flavonoids from Alternanthera tenella Colla
    Z. Naturforsch. 61, 19-25 (2006).
  276. L.A. Boothby, R. Madabushi, V. Kumar, B.D. Bredland, R.C. Hatton, P.L. Doering, H. Derendorf
    Extended stability of oxytocin in Ringer’s Lactate Solution at 4 oC and 25 oC
    Hospital Pharmacy 41, 437-441 (2006).
  277. Y. Li, J. Peris, L. Zhong, H. Derendorf
    Microdialysis as a toll in local pharmacodynamics
    AAPS Journal 8, E222-235 (2006).
  278. M. Brunner, H. Derendorf
    Clinical microdialysis: Current applications and potential use in drug development
    Trends in Analytical Chemistry (in press).
  279. V. Kumar, R. Madabushi, L.A. Boothby, B.D. Breland, R.C. Hatton, P.L. Doering, H. Derendorf
    Development and validation of an HPLC method for oxytocin in Ringer’s lactate and its application in stability analysis
    J. Liq. Chromatog. Rel. Technol. (in press).
  280. O. Burkhardt, C. Lehmann, R. Madabushi, V. Kumar, H. Derendorf, T. Welte
    Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistant development?
    J. Antimicrob. Chemother. (2006).
  281. O. Burkhardt, M. Brunner, S. Schmidt, M. Grant, Y. Tang, H. Derendorf
    Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by microdialysis
    J. Antimicrob. Chemother. 58, 632-636 (2006).
  282. U. Theuretzbacher, F. Ihle, H. Derendorf
    Pharmacokinetic/pharmacodynamic profile of voriconazole
    Clin. Pharmacokin. 45, 649-663 (2006).
  283. C.J. Clancy, H. Huang, S. Cheng, H. Derendorf, M.H. Nguyen
    Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments
    Antimicrob. Agents Chemother. 50, 2569-2572 (2006).
  284. V.A. Bhattaram, R. Madabushi, H. Derendorf
    Role of Food and Drug Administration in drug development
    in K.C. M. Campbell, Pharmacology and Ototoxicity for Audiologists, Thomson Delmar Learning, Clifton Park NY, pg. 33-45 (2006).
  285. V. Butterweck, H. Derendorf
    Pharmacokinetics of botanical products
    In Y.W.F. Lam, S.M. Huang, S. Hall (Ed.), Herbal Supplements-Drug Interactions, Marcel Dekker, p.205-244 (2006).
  286. S.U. Mertens-Talcott, P. Jilma-Stohlawetz, J. Rios, L. Hingorani, H. Derendorf
    Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L.) polyphenols after ingestion of a standardized extract in healthy human volunteers
    J. Agric. Food Chem. 54, 8956-8961 (2006).
  287. W.V. De Castro, M.A. Pires, C.D. Vianna-Soares, E.A. Nunan, G.A. Pianetti, L.M. Moreira-Campos, S.U. Mertens-Talcott, H. Derendorf
    The influence of formulation on the dissolution profile of diclofenac sodium tablets
    Drug Dev. Ind. Pharm. 32, 1103-1109 (2006).
  288. O. Burkhardt, H. Derendorf, D. Jäger, V. Kumar, R. Madabushi, K. Rohl, J. Barth
    Moxifloxacin distribution in the interstitial space of infected decubitus ulcer tissue of patients with spinal cord injury measured by in vivo microdialysis
    Scand. J. Infect. Dis. 38, 904-908 (2006).
  289. E.O. Meltzer, H. Derendorf
    The systemic safety of inhaled corticosteroid therapy: a focus on ciclesonide
    Ann Allergy Asthma Immunol. 97, 149-157 (2006).
  290. H. Derendorf, R. Nave, A. Drollmann, F. Cerasoli, W. Wurst
    Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma
    Eur. Respir. J. 28, 1042-1050 (2006).
  291. S.U. Mertens-Talcott, I. Zadezensky, W.V. De Castro, H. Derendorf, V. Butterweck
    Grapefruit-Drug Interactions: Can Interactions with drugs be avoided?
    J. Clin. Pharmacol. 46, 1390-1416 (2006).
  292. V. Kumar, S. Mostafa, M.W. Kayo, E.P. Goldberg, H. Derendorf
    HPLC Determination of dexamethasone in human plasma and its application to an in vitro release study from endovascular stents
    Pharmazie 61, 908-911 (2006).
  293. J.A. Manthey, K Myung, S. Mertens-Talcott, H. Derendorf, V. Butterweck, W.W. Widmer, The isolation of minor-occuring furanocoumarins in grapefruit and analysis of their inhibition of CYP3A4 and P-glycoprotein transport of talinolol from Caco-2 cells, Proc. Fla. State Hort. Soc. 119, 361-366 (2006)
  294. O. Burkhardt, V. Kumar, D. Katterwe, J. Majcher-Peszynska, B. Drewelow, H. Derendorf, T. Welte
    Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: Pharmacokinetics with special consideration on the free drug concentration
    J. Antimicrob. Chemother. 59, 277-284 (2007).
  295. W. Treyaprasert, S.Schmidt, K.H. Rand, U. Suvanakoot, H.Derendorf
    Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains
    Int. J. Antimicrob. Agents 29, 263-270 (2007).
  296. M. Vogt, H. Derendorf, J. Kramer, H.E. Junginger, K.K. Midha, V.P. Shah, S. Stavchansky, J.B. Dressman, D.M. Barends
    Biowaiver monographs for immediate release solid oral dosage forms: Prednisolone
    J. Pharm. Sci. 96, 27-37 (2007).
  297. O. Burkhardt, H. Derendorf, T. Welte
    Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice
    Expert Opin Pharmacother. 8, 237-56 (2007).
  298. H. Derendorf
    Clinical trials and dipyridamole formulation selection
    Cerebrovasc Dis. 23, 72-73 (2007).
  299. J. Xu, J. Winkler, H. Derendorf
    A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma
    J Pharmacokinet. Pharmacodyn. 34, 355-372 (2007).
  300. H. Derendorf, M. Hbner, B. Drewelow, U. Fuhr, C.H. Gleiter, B. Lemmer, G. Mikus, I. Roots, A. Ziegler, D. Ukena, Pharmacokinetics and pharmacodynamics of ciclesonide, Arzneimitteltherapie 25, 89-94 (2007).
  301. C.S.Chaurasia, M. Müller, E.D. Bashaw, E. Benfeldt, J. Bolinder, R. Bullock, P.M. Bungay, E.C.M. DeLange, H. Derendorf, W.F. Elmquist, M. Hammarlund-Udenaes, C. Joukhadar, D.L. Kellogg, C.E. Lunte, C.H. Nordstrom, H. Rollema, R.J. Sawchuk, B.W.Y. Cheung, V.P. Shah, L. Stahle, U. Ungerstedt, D.F. Welty, H. Yeo, AAPS-FDA workshop white paper: Microdialysis principles, application and regulatory perspectives
    J. Clin. Pharmacol. 47, 589-603 (2007).
  302. H. Derendorf
    Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide
    J. Clin. Pharmacol. 47, 782-789(2007).
  303. S. Schmidt, E. Schuck, V. Kumar, O. Burkhardt, H. Derendorf,
    Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents - minimum inhibitory concentrations vs kill curves.
    Expert Opin. Drug Discov. 2, 849-860(2007).
  304. S.U. Mertens-Talcott, W.V. De Castro, J.A. Manthey, H. Derendorf, V. Butterweck
    Polymethoxylated flavones and other phenolic derivatives from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells
    J. Agric. Food Chem. 55, 2563-2568(2007).
  305. M. Vogt, H. Derendorf, J. Kramer, H.E. Junginder, K.K. Midha, V.P. Shah, S. Stavchansky, J.B. Dressman, D.M. Barends
    Biowaiver monographs for immediate release solid oral dosage forms: prednisone.
    J. Pharm. Sci. 96, 1480-1489(2007).
  306. W.V. De Castro, S.U. Mertens-Talcott, H. Derendorf, V. Butterweck
    Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells.
    J. Pharm. Sci. 96, 2808-2817(2007).
  307. Y. Li, H. Nguyen, H. Derendorf, S. Chen, C.J. Clancy
    Measurement of voriconazole activity against Candida albicans, C. glabrata and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.
    Antimicrob. Agents Chemother. 51, 2985-2987(2007).
  308. M. Lobmeyer, S. Schmidt, H. Derendorf
    Pharmacogenetics and personalized medicine
    Deutsche Apotheker Zeitung (2007).
  309. H. Derendorf, K.S. Estes
    The significance of optimized formulation for dipyridamole in stroke risk reduction
    European Neurological Disease 2007 (II), 21-23 (2007).
  310. O. Burkhardt, H. Derendorf
    Grundlage der Pharmackotherapie beim kritisch Kranken, In "Intensivmedizin", edited by H. Van Aken, K. Reinhart, M. Zimpfer, T. Welte,
    Thieme, 476-486 (2007)
  311. Y. Li, M.H. Nguyen, S. Cheng, S. Schmidt, L. Zhong, H. Derendorf, C.J. Clancy
    A pharmacokinetic/pharmacodynamic mathematical model accurately describes the activity of voriconazole against Candida spp. in vitro
    Int. J. Antimicrob. Agents (2008).
  312. J.W. Mouton, U. Theuretzbacher, W.A. Craig, P.MM. Tulkens, H. Derendorf, O. Cars
    Tissue concentrations: Do we ever learn?
    J Antimicrob Chemother. 61, 235-237 (2008).
  313. F.B. Mayr, A.O. Spiel, J.M. Leitner, C. Firbas, T. Kliegel, P. Jilma-Stohlawetz, H. Derendorf, B. Jilma
    Duffy antigen modifies the chemokine response in human endotoxemia
    Crit Care Med. 36, 159-165 (2008).
  314. S. Schmidt, R. Banks, V. Kumar, K.H. Rand, H. Derendorf
    Clinical microdialysis in skin and soft tissues: an update.
    J Clin Pharmacol. 48, 351-364 (2008).
  315. B. Meibohm, H. Derendorf
    Pharmacokinetics and pharmacoynamics of biotech drugs In "Pharmacology - From Drug Development to Gene Therapy", edited by R.A. Meyers, 107-136, Wiley-VCH, Weinheim (2008)
  316. J. xu, J. Winkler, Sn>n. Sabarinath, H. Derendorf
    Assessment of the impact of dosing time on the pharmacokinetics/pharmacodynamics of prednisolone
    The AAPS Journal 2008 Supplement 1 (IV Administration) and Supplement 2 (Oral Administration)
  317. C. Scheerans, H. Derendorf, C. Kloft
    Proposal for a standardized identification of the mono-exponential terminal phase for orally administered drugs
    Biopharm. Drug. Dispos. 29, 145-157 (2008).
  318. V. Butterweck, H. Derendorf
    Potential of pharmacokinetic profiling for detecting herbal interactions with drugs
    Clin. Pharmacokin. 47, 383-397(2008)
  319. S. Schmidt, A. Barbour, M. Sahre, K.H. Rand, H. Derendorf
    PK/PD: new insights for antibacterial and antiviral applications
    Curr Opinion Pharmacol, 8, 108 (2008)
  320. K. blake, r. Madabushi, H. Derendorf, J. Lima
    Population pharmacodynamic model of bronchodilator response to inhaled albuterol in children and adults with asthma
    Chest, 134, 981-989 (2008)
  321. W.V. de Castro, S. Mertens-Talcott, H. Derendorf, V. Butterweck
    Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats
    J Agric Food Chem, 56, 4840-4845 (2008)
  322. H. Derendorf, E.O. Meltzer
    Molecular and clinical pharmacology of intranasal corticosteroids: Clinical and therapeutic implications
    Allergy 63, 1292-1300 (3008)
  323. H. Badrane, M.H. Nguyen, S. cheng, V. Kumar, H. Derendorf, K.A. Iczkowski, C.J. Clancy
    The Candida albicans phosphatase Inp51p interacts with the EH domain protein Irs4p, regulates phosphatidylinositol-4, 5-bisphosphate levels and influences hyphal formation, the cell integrity pathway and virulence
    Microbiology, 154, 3296-3308 (2008)
  324. S. Schmidt, K. Rock, M. Sahre, O. Burkhardt, M. Brunner, M.T. Lobeyer, H. Derendorf
    Effect of protein binding on the pharmacological activity of highly bound antibiotics
    Antimicrob. Agents Chemother. 52, 3994-04000 (2008)
  325. S.U. Mertens-Talcott, J. Rios, P. Jilma-Stohlawetz, L.A. Pacheco-Palencia, B. Meibohm, S.T. Talcott, H. Derendorf
    Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers
    J. Agric. Food Chem. 56, 7796-7802 (2008)
  326. J. Liu, H. Pan, M.S. Gold, H. Derendorf, A.W. Bruijnzeel
    Effects of fentanyl dose and exposure duration on the affective and somatic signs of fentanyl withdrawal in rats
    Neuropharmacology, 55, 812-818 (2008)
  327. J. Xu, S.N. Sabarinath, H. Derendorf
    Cortisol suppression as a surrogate marker for inhaled corticosteroid-induced growth retardation in children
    Eur J Pharm Sci. 36, 110-121 (2009)
  328. O.G. Ghobrial, H. Derendorf, H.D. Hillman
    Pharmacodynamic activity of the lantibiotic MU1140
    Int. J. Antimicrob. Agents, 33, 70-74(2009)

 


Email your request for a reprint (please include the number of the reprint)
to: hartmut@cop.ufl.edu


Return to Top of the List

 Last modified January 6, 2009